InsiderTrades

Form 4 for ONC BeOne Medicines Ltd.

Accepted 2021-09-02 00:00:00 ET · period of report 2021-08-31 · accession 0001651308-21-000188 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2021-09-02 2021-08-31+ ONC Huang Jane CMO, Hematology A - Grant $0.00 +15.4K 305.8K +5% $0
M 2021-09-02 2021-09-01+ ONC Huang Jane CMO, Hematology S - Sale $318.88 -1,087 0 -100% -$346.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2021-09-01 A A 7,124 $0.00 312,948 D — — (F1) Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
2 Common American Depositary Shares 2021-08-31 A A 542 $0.00 542 D — — (F2) Each American Depositary Share represents 13 Ordinary Shares. (F1) Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
3 Common American Depositary Shares 2021-09-01 A A 545 $0.00 545 D — — (F2) Each American Depositary Share represents 13 Ordinary Shares. (F1) Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
4 Common American Depositary Shares 2021-09-02 S D 545 $327.18 0 D — — (F2) Each American Depositary Share represents 13 Ordinary Shares.
5 Common Ordinary Shares 2021-08-31 A A 7,163 $0.00 305,824 D — — (F1) Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
6 Common American Depositary Shares 2021-09-01 S D 542 $310.53 0 D — — (F2) Each American Depositary Share represents 13 Ordinary Shares.